PGIM Jennison Health Sciences Fund- Class R6 (PHLQX) - Health fund with $2.61 Billion in assets. The fund allocates 49.64% of its portfolio to its top 10 holdings. It primarily invests in averagemarketcap cap stocks , with a focus on the cash and equivalents sector.
The largest holding in the fund is Eli Lilly Co at 16.48% of total assets. This is followed by UnitedHealth Group Inc (2.68%) and Amgen Inc (4.85%).
| Name | Weight | Owned | Change |
|---|---|---|---|
| Eli Lilly Co | 16.48% | - | - |
| UnitedHealth Group Inc | 2.68% | - | - |
| Amgen Inc | 4.85% | - | - |
| Bristol-Myers Squibb Co | 4.80% | - | - |
| Vertex Pharmaceuticals Inc | 2.91% | - | - |
| Novo Nordisk A/S | 3.67% | - | - |
| Boston Scientific Corp | 3.44% | - | - |
| Argenx SE | 4.62% | - | - |
| Humana Inc | 3.39% | - | - |
| AstraZeneca PLC | 2.80% | - | - |
| Abbott Laboratories | 4.44% | - | - |
| (PIPA070) PGIM Core Government Money Market Fund | 7.72% | - | - |
| Intuitive Surgical Inc | 4.16% | - | - |
| Neurocrine Biosciences Inc | 2.90% | - | - |
| PGIM Institutional Money Market Fund - D | 6.27% | - | - |
| Thermo Fisher Scientific Inc | 5.39% | - | - |
| Gilead Sciences Inc | 3.69% | - | - |
| Danaher Corp | 5.01% | - | - |
| UCB SA | 3.14% | - | - |
| Eli Lilly Co. COM | 16.77% | - | - |
| Merck Co., Inc COM | 6.02% | - | - |
| Gilead Sciences Inc. COM | 4.37% | - | - |
| UnitedHealth Group Inc. COM | 4.31% | - | - |
| Vertex Pharmaceuticals Incorporated COM | 3.56% | - | - |
| CVS Health Corp COM | 3.27% | - | - |
| Lonza Group AG CHF1 (REGD) | 3.13% | - | - |
| Argenx SE SPONSORED ADR | 3.10% | - | - |
| Regeneron Pharmaceuticals, Inc. COM | 3.07% | - | - |